| Bioactivity | Sunitinib-d10 is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2]. | ||||||||||||
| Name | Sunitinib-d10 | ||||||||||||
| CAS | 1126721-82-1 | ||||||||||||
| Formula | C22H17D10FN4O2 | ||||||||||||
| Molar Mass | 408.54 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Sunitinib-d10
CAS: 1126721-82-1 F: C22H17D10FN4O2 W: 408.54
Sunitinib-d10 is a deuterium labeled Sunitinib. Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor with IC
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.